BioCentury
ARTICLE | Clinical News

Nuclear Matrix Protein-based immunoassay: NMPS began pivotal testing to detect colorectal cancer

October 7, 1996 7:00 AM UTC

Matritech Inc. (NMPS), Newton, Mass. Product: Nuclear Matrix Protein-based immunoassay Indication: Colorectal cancer Status: NMPS began pivotal testing of its immunoassay to detect colorectal cancer,...